We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 7,000 results
  1. Modeling Acute Myeloid Leukemia Using StarPEG-Heparin Hydrogels

    Biomimetic semi-synthetic hydrogels formed from a combination of star-shaped poly(ethylene glycol) (starPEG) and the glycosaminoglycan, heparin,...
    P. Lewen Holloway, Akhilandeshwari Ravichandran, ... Laura J. Bray in 3D Cell Culture
    Protocol 2024
  2. Emerging role of glutathione peroxidase 4 in myeloid cell lineage development and acute myeloid leukemia

    Phospholipid Hydroperoxide Gluthatione Peroxidase also called Glutathione Peroxidase 4 is one of the 25 described human selenoproteins. It plays an...

    Patrick Auberger, Cécile Favreau, ... Guillaume Robert in Cellular & Molecular Biology Letters
    Article Open access 08 July 2024
  3. Crosstalk between autophagy and metabolism: implications for cell survival in acute myeloid leukemia

    Acute myeloid leukemia (AML), a prevalent form of leukemia in adults, is often characterized by low response rates to chemotherapy, high recurrence...

    Yongfeng Chen, Jia Chen, ... **g Li in Cell Death Discovery
    Article Open access 24 January 2024
  4. RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

    Background

    The oncogenic protein HOXA9 plays a critical role in leukemia transformation and maintenance, and its aberrant expression is a hallmark of...

    Mengli Zhang, Judith Hyle, ... Peng Xu in Genome Biology
    Article Open access 12 January 2024
  5. A novel function of STAT3β in suppressing interferon response improves outcome in acute myeloid leukemia

    Signal transducer and activator of transcription 3 (STAT3) is frequently overexpressed in patients with acute myeloid leukemia (AML). STAT3 exists in...

    Sophie Edtmayer, Agnieszka Witalisz-Siepracka, ... Dagmar Stoiber in Cell Death & Disease
    Article Open access 28 May 2024
  6. Invasive Aspergillosis in Patients with Acute Leukemia: Comparison Between Acute Myeloid and Acute Lymphoid Leukemia

    Background

    The epidemiology of invasive aspergillosis (IA) in patients with acute lymphoid leukemia (ALL) has not been well characterized.

    ...
    Arnaldo L. Colombo, Maria Daniela Bergamasco, ... Marcio Nucci in Mycopathologia
    Article 01 November 2022
  7. Parbendazole as a promising drug for inducing differentiation of acute myeloid leukemia cells with various subtypes

    Acute myeloid leukemia (AML) is a malignancy characterized by differentiation arrest of hematopoietic precursor cells. Differentiation therapy is...

    Hidemasa Matsuo, Aina Inagami, ... Souichi Adachi in Communications Biology
    Article Open access 24 January 2024
  8. Protein arginine methyltransferase 2 controls inflammatory signaling in acute myeloid leukemia

    Arginine methylation is catalyzed by protein arginine methyltransferases (PRMTs) and is involved in various cellular processes, including cancer...

    Camille Sauter, Thomas Morin, ... Laurent Delva in Communications Biology
    Article Open access 20 June 2024
  9. SFXN3 is a Prognostic Marker and Promotes the Growth of Acute Myeloid Leukemia

    Acute myeloid leukemia (AML) is a heterogeneous disease with rapid progression and frequent mutations. Sideroflexin3 (SFXN3) has been shown to be...

    Fengbo **, Limei He, ... Mingzhen Yang in Cell Biochemistry and Biophysics
    Article Open access 14 June 2024
  10. Macrophage migration inhibitory factor blockade reprograms macrophages and disrupts prosurvival signaling in acute myeloid leukemia

    The malignant microenvironment plays a major role in the development of resistance to therapies and the occurrence of relapses in acute myeloid...

    Caroline Spertini, Alexandre P. Bénéchet, ... Tatiana Smirnova in Cell Death Discovery
    Article Open access 28 March 2024
  11. Targeting a lineage-specific PI3Kɣ–Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule

    Dose-limiting toxicity poses a major limitation to the clinical utility of targeted cancer therapies, often arising from target engagement in...

    Lois M. Kelly, Justine C. Rutter, ... Alexandre Puissant in Nature Cancer
    Article 30 May 2024
  12. Identifying key genes and functionally enriched pathways in acute myeloid leukemia by weighted gene co-expression network analysis

    Acute myeloid leukemia (AML) is characterized by the uncontrolled proliferation of myeloid leukemia cells in the bone marrow and other hematopoietic...

    Jimo Jian, Chenglu Yuan, Hongyuan Hao in Journal of Applied Genetics
    Article 09 July 2024
  13. Proteinase 3 depletion attenuates leukemia by promoting myeloid differentiation

    Hematopoietic stem and progenitor cells (HSPCs) that have impaired differentiation can transform into leukemic blasts. However, the mechanism that...

    Huan Liu, Lu Sun, ... Yuanfu Xu in Cell Death & Differentiation
    Article Open access 08 April 2024
  14. Sox13 and M2-like leukemia-associated macrophages contribute to endogenous IL-34 caused accelerated progression of acute myeloid leukemia

    Interleukin 34 (IL-34) mainly plays physiologic and pathologic roles through the sophisticated multi-ligand signaling system, macrophage...

    Dongyue Zhang, **aoxi Cui, ... Guoguang Zheng in Cell Death & Disease
    Article Open access 06 May 2023
  15. Deep genomic characterization highlights complexities and prognostic markers of pediatric acute myeloid leukemia

    Pediatric acute myeloid leukemia (AML) is an uncommon but aggressive hematological malignancy. The poor outcome is attributed to inadequate...

    Chi-Keung Cheng, Yuk-Lin Yung, ... Margaret H. L. Ng in Communications Biology
    Article Open access 31 March 2023
  16. The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia

    Acute myeloid leukemia (AML) with mixed-lineage leukemia ( MLL ) gene rearrangements (MLL-r) is an aggressive subtype of blood cancer with dismal...

    Wenqi Wu, Yanan Jiang, ... Zhigang Zhao in Cell Death Discovery
    Article Open access 01 May 2024
  17. Oncogenic lncRNA FAM215A promotes the malignant cell phenotypes of acute myeloid leukemia (AML) cell lines

    Acute myeloid leukemia (AML) is a form of blood cancer that arise as a result of clonal proliferation of malignant myeloid precursors acquiring...

    Lin Li, Liuyan **n, ... Zhengrong Zou in Journal of Molecular Histology
    Article 02 January 2024
  18. Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia

    Immunotherapy has attracted considerable attention as a therapeutic strategy for cancers including acute myeloid leukemia (AML). In this study, we...

    Emi Sugimoto, **gmei Li, ... Susumu Goyama in Communications Biology
    Article Open access 21 December 2023
  19. Ningetinib, a novel FLT3 inhibitor, overcomes secondary drug resistance in acute myeloid leukemia

    Background

    FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) is a common mutation type in acute myeloid leukemia (AML) and is usually...

    Chuhong Hu, Yvyin Zhang, ... Peihong Wang in Cell Communication and Signaling
    Article Open access 08 July 2024
  20. Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia

    Blocked cellular differentiation is a critical pathologic hallmark of acute myeloid leukemia (AML). Here, we showed that genetic activation of the...

    Chunyang Yi, Jiacheng He, ... Weiqiang Lu in Cell Death & Disease
    Article Open access 27 November 2022
Did you find what you were looking for? Share feedback.